Literature DB >> 27255251

Epithelium-on corneal collagen crosslinking for management of advanced keratoconus.

Shihao Chen1, Tommy C Y Chan1, Jia Zhang1, Ping Ding1, Jason C K Chan1, Marco C Y Yu1, Yini Li1, Vishal Jhanji2, Qinmei Wang1.   

Abstract

PURPOSE: To report the 1-year visual and keratometric results of epithelium-on corneal collagen crosslinking (CXL) for advanced keratoconus (median maximum keratometry [K] ≥58.0 diopters [D]).
SETTING: School of Ophthalmology and Optometry and Eye Hospital of Wenzhou Medical College, Wenzhou, China.
DESIGN: Prospective case series.
METHODS: Patients with bilateral progressive keratoconus had tetracaine-enhanced epithelium-on CXL. The worse eye had CXL, and the fellow eye was not treated. Results were reported 1, 3, 6, and 12 months postoperatively. The outcomes were compared with those in the fellow untreated eyes.
RESULTS: Twenty-one eyes of 21 patients with a median age of 20.4 years (interquartile range [IQR], 9.5 years) were treated. A significant improvement in postoperative uncorrected distance visual acuity was observed at 12 months (P = .002). Postoperative corrected distance visual acuity improved at 6 months and 12 months (P ≤ .009) compared with baseline values. The maximum K decreased by 1.63 D from the median preoperative maximum K of 62.7 D (IQR, 12.9 D) at 12 months (P < .001). The reduction in maximum K was higher after CXL than in untreated eyes at the end of 12 months (P = .001). Correlation analysis between the preoperative maximum K values and the change over 6 to 12 months between different studies showed a significant correlation (r = -0.764, P < .001; Spearman correlation).
CONCLUSIONS: Epithelium-on CXL was an effective treatment for patients with advanced keratoconus. A higher preoperative maximum K value correlated with greater corneal flattening after CXL. FINANCIAL DISCLOSURE: None of the authors has a financial or proprietary interest in any material or method mentioned.
Copyright © 2016 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27255251     DOI: 10.1016/j.jcrs.2016.02.041

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  8 in total

1.  Corneal crosslinking for keratoconus in Japanese populations: one year outcomes and a comparison between conventional and accelerated procedures.

Authors:  Naoko Kato; Kenji Konomi; Megumi Shinzawa; Kozue Kasai; Takeshi Ide; Ikuko Toda; Chikako Sakai; Kazuno Negishi; Kazuo Tsubota; Jun Shimazaki
Journal:  Jpn J Ophthalmol       Date:  2018-07-10       Impact factor: 2.447

2.  Comparison of deep anterior lamellar keratoplasty and corneal cross-linking in patients with advanced keratoconus.

Authors:  Jinsong Xue; Haiou Wang; Min Wang; Qingyan Zeng; Vishal Jhanji; Andy D Kim; Michael T M Wang; Yingnan Xu; Xiuming Jin; Wei Chen
Journal:  Jpn J Ophthalmol       Date:  2021-11-29       Impact factor: 2.447

Review 3.  Adverse events after riboflavin/UV-A corneal cross-linking: a literature review.

Authors:  Sebastiano Serrao; Giuseppe Lombardo; Marco Lombardo
Journal:  Int Ophthalmol       Date:  2021-08-27       Impact factor: 2.031

4.  Efficacy and safety of transepithelial collagen cross linking for progressive keratoconus.

Authors:  Sameer Shahid Ameen; Mohammad Asim Mehboob; Kashif Ali
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

5.  Long-Term Follow-Up of Accelerated Transepithelial Corneal Crosslinking for Post-LASIK Ectasia: A Pilot Prospective Observational Study.

Authors:  Mi Tian; Xiaoyu Zhang; Weijun Jian; Ling Sun; Yang Shen; Xingtao Zhou
Journal:  Front Bioeng Biotechnol       Date:  2021-12-22

6.  Topography-Guided Transepithelial Accelerated Corneal Collagen Cross-Linking for Low Refractive Error Correction in Keratoconus Treatment: A Pilot Study.

Authors:  Ling Sun; Xiaoyu Zhang; Mi Tian; Yang Shen; Jing Zhao; Xingtao Zhou
Journal:  Front Bioeng Biotechnol       Date:  2022-02-23

7.  Comparison of ocular discomfort after three different epithelial debridement techniques for corneal collagen cross-linking in keratoconus treatment.

Authors:  Hosamadden Alkayid; Leyla Asena; Aslihan Yüce; Meriç Yavuz Çolak; Dilek Dursun Altınörs
Journal:  Ther Adv Ophthalmol       Date:  2021-06-23

8.  Transepithelial accelerated corneal crosslinking for keratoconus eyes with maximum keratometry values larger than 58 diopters.

Authors:  Ling Sun; Jing Zhao; Xiaoyu Zhang; Yang Shen; Mi Tian; Xingtao Zhou
Journal:  J Cataract Refract Surg       Date:  2022-02-01       Impact factor: 3.351

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.